- Home
- KFS vs CMPS Comparison
KFS vs CMPS Comparison
Compare KFS & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KFS
- CMPS
- Stock Information
- Founded
- KFS 1989
- CMPS 2020
- Country
- KFS United States
- CMPS United Kingdom
- Employees
- KFS N/A
- CMPS N/A
- Industry
- KFS Property-Casualty Insurers
- CMPS Biotechnology: Pharmaceutical Preparations
- Sector
- KFS Finance
- CMPS Health Care
- Exchange
- KFS Nasdaq
- CMPS Nasdaq
- Market Cap
- KFS 220.3M
- CMPS 246.5M
- IPO Year
- KFS 1996
- CMPS 2020
- Fundamental
- Price
- KFS $8.09
- CMPS $3.13
- Analyst Decision
- KFS
- CMPS Strong Buy
- Analyst Count
- KFS 0
- CMPS 6
- Target Price
- KFS N/A
- CMPS $20.20
- AVG Volume (30 Days)
- KFS 109.1K
- CMPS 913.7K
- Earning Date
- KFS 05-07-2025
- CMPS 05-07-2025
- Dividend Yield
- KFS N/A
- CMPS N/A
- EPS Growth
- KFS N/A
- CMPS N/A
- EPS
- KFS N/A
- CMPS N/A
- Revenue
- KFS $112,710,000.00
- CMPS N/A
- Revenue This Year
- KFS N/A
- CMPS N/A
- Revenue Next Year
- KFS N/A
- CMPS N/A
- P/E Ratio
- KFS N/A
- CMPS N/A
- Revenue Growth
- KFS 3.29
- CMPS N/A
- 52 Week Low
- KFS $7.06
- CMPS $2.49
- 52 Week High
- KFS $9.58
- CMPS $9.63
- Technical
- Relative Strength Index (RSI)
- KFS 57.21
- CMPS 51.00
- Support Level
- KFS $7.28
- CMPS $2.94
- Resistance Level
- KFS $8.14
- CMPS $3.11
- Average True Range (ATR)
- KFS 0.33
- CMPS 0.21
- MACD
- KFS 0.03
- CMPS 0.07
- Stochastic Oscillator
- KFS 60.45
- CMPS 98.46
About KFS Kingsway Financial Services Inc. (DE)
Kingsway Financial Services Inc through subsidiaries operates in the extended warranty and business services industries in the United States. The company operates through segments namely, Extended Warranty and Kingsway Search Xcelerator. The Extended Warranty segment provides after-market vehicle protection services distributed by credit unions. The firm generates maximum revenue from the Extended Warranty segment in the form of Service fee and commission income.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.